Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mercaptopurine × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 133 Lymphoid 117 Myeloid 4 Sarcoma 3 CNS 2 Tumor-Agnostic 1 Other 1 Gynecologic 1 Classical hematology 1 Breast 1

Conditions

Neoplasm Metastasis 1

Interventions

pembrolizumab 83 Paclitaxel 72 Carboplatin 66 Gemcitabine 65 Surveys and Questionnaires 57 Nivolumab 52 Cisplatin 48 Docetaxel 47 Bevacizumab 46 Magnetic Resonance Spectroscopy 43 Fluorouracil 38 Capecitabine 38 Blood Specimen Collection 38 Radiotherapy 36 Irinotecan 32 Oxaliplatin 31 Biopsy 31 Pemetrexed 30 Erlotinib Hydrochloride 30 Specimen Handling 29 Standard of Care 28 atezolizumab 27 Trastuzumab 27 Leucovorin 26 Sorafenib 24 Radiosurgery 24 Ipilimumab 24 Everolimus 24 Interviews as Topic 23 Drug Therapy 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05276284 2026-01-14

TEMPLE

Rigshospitalet, Denmark

Phase 1/2 Completed

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡